research information

Study time

2016.1-2019.10

Country

China

Object

All patients with PCa were screened and incorporated into the fil alysis on the grounds of the following eligibility criteria: (1) total serum PSA ≥10 ng/mL or Gleason score ≥7 or localized T2b or T2c stage; (2) patients undergoing RARP or LRP for localized PCa; (3) no clinical evidence of positive lymph nodes or clinical T3-4 stage

Inclusion criteria

Patients with D'Amico low-risk PCa, contraindications for RP, neoadjuvant hormone therapy, or suspected extracapsular extension in the preoperative evaluation were excluded from this study.

Robots remarks

the da Vinci Si system

Sample size

232 

Topic classification

Comparison of surgical techniques

Keypoint

For the surgical magement of intermediate- and high-risk localized PCa, RARP tended to a lower risk of ≤ Grade II complications and superior functiol preservation without cancer control being compromised than LRP.

Year